Form 8-K - Current report:
SEC Accession No. 0001104659-25-020349
Filing Date
2025-03-04
Accepted
2025-03-04 16:30:21
Documents
23
Period of Report
2025-03-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm258193-1_8k.htm   iXBRL 8-K 32001
2 EXHIBIT 4.1 tm258193d1_ex4-1.htm EX-4.1 92997
3 EXHIBIT 4.2 tm258193d1_ex4-2.htm EX-4.2 84058
4 EXHIBIT 4.3 tm258193d1_ex4-3.htm EX-4.3 45938
5 EXHIBIT 5.1 tm258193d1_ex5-1.htm EX-5.1 21306
6 EXHIBIT 10.1 tm258193d1_ex10-1.htm EX-10.1 184252
10 GRAPHIC tm258193d1_ex4-1img001.jpg GRAPHIC 4733
11 GRAPHIC tm258193d1_ex4-2img003.jpg GRAPHIC 4739
12 GRAPHIC tm258193d1_002.jpg GRAPHIC 3003
13 GRAPHIC tm258193d1_003.jpg GRAPHIC 3003
14 GRAPHIC tm258193d1_004.jpg GRAPHIC 3063
  Complete submission text file 0001104659-25-020349.txt   777744

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA btai-20250303.xsd EX-101.SCH 3048
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE btai-20250303_lab.xml EX-101.LAB 34240
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btai-20250303_pre.xml EX-101.PRE 22381
25 EXTRACTED XBRL INSTANCE DOCUMENT tm258193-1_8k_htm.xml XML 3562
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38410 | Film No.: 25705129
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)